(Total Views: 370)
Posted On: 12/20/2017 12:44:54 AM
Post# of 30038
Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery
Total cost: EUR 8 705 549,75
EU contribution: EUR 5 971 173,75
http://cordis.europa.eu/project/rcn/207208_en.html
Total cost: EUR 8 705 549,75
EU contribution: EUR 5 971 173,75
http://cordis.europa.eu/project/rcn/207208_en.html
(5)
(0)Scroll down for more posts ▼
